Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2021 Feb;47(1):61-72.
doi: 10.1111/nan.12625. Epub 2020 May 19.

TDP43 proteinopathy is associated with aberrant DNA methylation in human amyotrophic lateral sclerosis

C Appleby-Mallinder  1 , E Schaber  1 , J Kirby  1 , P J Shaw  1 , J Cooper-Knock  1 , P R Heath  1 , J R Highley  1   2
Affiliations
Free article

TDP43 proteinopathy is associated with aberrant DNA methylation in human amyotrophic lateral sclerosis

C Appleby-Mallinder et al. Neuropathol Appl Neurobiol. 2021 Feb.
Free article

Abstract

Background: Amyotrophic lateral sclerosis (ALS) is a fatal neurodegenerative disease characterized by motor neurone (MN) degeneration and death. ALS can be sporadic (sALS) or familial, with a number of associated gene mutations, including C9orf72 (C9ALS). DNA methylation is an epigenetic mechanism whereby a methyl group is attached to a cytosine (5mC), resulting in gene expression repression. 5mC can be further oxidized to 5-hydroxymethylcytosine (5hmC). DNA methylation has been studied in other neurodegenerative diseases, but little work has been conducted in ALS.

Aims: To assess differences in DNA methylation in individuals with ALS and the relationship between DNA methylation and TDP43 pathology.

Methods: Post mortem tissue from controls, sALS cases and C9ALS cases were assessed by immunohistochemistry for 5mC and 5hmC in spinal cord, motor cortex and prefrontal cortex. LMNs were extracted from a subset of cases using laser capture microdissection. DNA from these underwent analysis using the MethylationEPIC array to determine which molecular processes were most affected.

Results: There were higher levels of 5mC and 5hmC in sALS and C9ALS in the residual lower motor neurones (LMNs) of the spinal cord. Importantly, in LMNs with TDP43 pathology there was less nuclear 5mC and 5hmC compared to the majority of residual LMNs that lacked TDP43 pathology. Enrichment analysis of the array data suggested RNA metabolism was particularly affected.

Conclusions: DNA methylation is a contributory factor in ALS LMN pathology. This is not so for glia or neocortical neurones.

Keywords: DNA hydroxymethylation; DNA methylation; amyotrophic lateral sclerosis; epigenetics; motor neurone disease.

PubMed Disclaimer

References

    1. Charcot JM, Joffory A. Deux cas d’atrophie musculaire progressive avec lesions de la substance grise et des faisceaux antero-lateraux de la moelle epiniere. Arch Physiol Neurol Pathol 1869; 2: 744-54
    1. Ludolph A, Drory V, Hardiman O, Nakano I, Ravits J, Robberecht W, et al. A revision of the El Escorial criteria - 2015. Amyotroph Lateral Scler Frontotemporal Degener 2015; 16: 291-2.
    1. Harwood CA, McDermott CJ, Shaw PJ. Physical activity as an exogenous risk factor in motor neuron disease (MND): a review of the evidence. Amyotroph Lateral Scler 2009; 10: 191-204
    1. Niccoli T, Partridge L, Isaacs AM. Ageing as a risk factor for ALS/FTD. Hum Mol Genet 2017; 26: R105-13
    1. Ince PG, Highley JR, Kirby J, Wharton SB, Takahashi H, Strong MJ, et al. Molecular pathology and genetic advances in amyotrophic lateral sclerosis: an emerging molecular pathway and the significance of glial pathology. Acta Neuropathol 2011; 122: 657-71

Publication types

MeSH terms